FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3020130780> ?p ?o ?g. }

• W3020130780 abstract "Abstract Background Exenatide, a glucagon like peptide 1 analog, has been suggested to reduce the cardiovascular disease risk factors, such as body weight, blood pressure and subclinical atherosclerosis in patients with type 2 diabetes mellitus (T2DM). This was the first randomized, open-label, controlled trial to compare the effects of exenatide versus insulin on subclinical atherosclerosis, as assessed by carotid-intima media thickness (CIMT), in patients with T2DM. Methods A total of 66 patients with T2DM admitted from March 10, 2015 to June 20, 2017 in the Department of Endocrinology, Beijing Hospital were randomized to receive twice-daily exenatide or aspartate 70/30 insulin for 52 weeks. The primary endpoint was change from baseline in CIMT, and secondary endpoints included changes at week 52 from baseline in body weight, glycemic markers, lipid metabolism markers, blood pressure, C-reactive protein, fibrinogen, 8-hydroxydeoxyguanosine, irisin, and brain natriuretic peptide. Results Exenatide more significantly reduced the CIMT from baseline compared with insulin after 52 weeks, with a mean difference of − 0.14 mm (95% interval confidence: − 0.25, − 0.02; P = 0.016). Weight and body mass index were both significantly reduced in the exenatide group over 52 weeks. Exenatide reduced total lipoprotein and low-density lipoprotein cholesterol levels more significantly than insulin at weeks 16 and 40. Correlation analyses showed that CIMT was positively correlated with low-density lipoprotein cholesterol. Conclusions Twice-daily exenatide could prevent atherosclerosis progression in patients with T2DM over a 52-week treatment period compared with insulin therapy. Trial registration Chinese Clinical Trial Registry ChiCTR-1800015658" @default.
• W3020130780 created "2020-05-01" @default.
• W3020130780 creator A5007240955 @default.
• W3020130780 creator A5032447166 @default.
• W3020130780 creator A5054153683 @default.
• W3020130780 creator A5073501391 @default.
• W3020130780 creator A5087828546 @default.
• W3020130780 creator A5090010252 @default.
• W3020130780 date "2020-04-25" @default.
• W3020130780 modified "2023-10-16" @default.
• W3020130780 title "Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial" @default.
• W3020130780 cites W1973333544 @default.
• W3020130780 cites W1991030758 @default.
• W3020130780 cites W1992519606 @default.
• W3020130780 cites W2002757015 @default.
• W3020130780 cites W2028272916 @default.
• W3020130780 cites W2033892901 @default.
• W3020130780 cites W2062883844 @default.
• W3020130780 cites W2070710390 @default.
• W3020130780 cites W2112912403 @default.
• W3020130780 cites W2118744821 @default.
• W3020130780 cites W2129377335 @default.
• W3020130780 cites W2135287300 @default.
• W3020130780 cites W2139377033 @default.
• W3020130780 cites W2142400535 @default.
• W3020130780 cites W2153003051 @default.
• W3020130780 cites W2186685774 @default.
• W3020130780 cites W2516683303 @default.
• W3020130780 cites W2522021563 @default.
• W3020130780 cites W2530160427 @default.
• W3020130780 cites W2558288750 @default.
• W3020130780 cites W2591687581 @default.
• W3020130780 cites W2751778625 @default.
• W3020130780 cites W2754041380 @default.
• W3020130780 cites W2757748853 @default.
• W3020130780 cites W2766792485 @default.
• W3020130780 cites W2776500739 @default.
• W3020130780 cites W2795481136 @default.
• W3020130780 cites W2884459120 @default.
• W3020130780 cites W2888943767 @default.
• W3020130780 cites W2899380388 @default.
• W3020130780 cites W2903035826 @default.
• W3020130780 cites W2912424797 @default.
• W3020130780 cites W2913157584 @default.
• W3020130780 cites W2943840111 @default.
• W3020130780 cites W2958724065 @default.
• W3020130780 cites W4240986128 @default.
• W3020130780 doi "https://doi.org/10.1186/s12933-020-01014-7" @default.
• W3020130780 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7183674" @default.
• W3020130780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32334592" @default.
• W3020130780 hasPublicationYear "2020" @default.
• W3020130780 type Work @default.
• W3020130780 sameAs 3020130780 @default.
• W3020130780 citedByCount "8" @default.
• W3020130780 countsByYear W30201307802022 @default.
• W3020130780 countsByYear W30201307802023 @default.
• W3020130780 crossrefType "journal-article" @default.
• W3020130780 hasAuthorship W3020130780A5007240955 @default.
• W3020130780 hasAuthorship W3020130780A5032447166 @default.
• W3020130780 hasAuthorship W3020130780A5054153683 @default.
• W3020130780 hasAuthorship W3020130780A5073501391 @default.
• W3020130780 hasAuthorship W3020130780A5087828546 @default.
• W3020130780 hasAuthorship W3020130780A5090010252 @default.
• W3020130780 hasBestOaLocation W30201307801 @default.
• W3020130780 hasConcept C126322002 @default.
• W3020130780 hasConcept C134018914 @default.
• W3020130780 hasConcept C168563851 @default.
• W3020130780 hasConcept C203092338 @default.
• W3020130780 hasConcept C2777180221 @default.
• W3020130780 hasConcept C2778163477 @default.
• W3020130780 hasConcept C2778270857 @default.
• W3020130780 hasConcept C2779306644 @default.
• W3020130780 hasConcept C2779339615 @default.
• W3020130780 hasConcept C2780221984 @default.
• W3020130780 hasConcept C2780533449 @default.
• W3020130780 hasConcept C2910068830 @default.
• W3020130780 hasConcept C2987047532 @default.
• W3020130780 hasConcept C555293320 @default.
• W3020130780 hasConcept C71924100 @default.
• W3020130780 hasConcept C84393581 @default.
• W3020130780 hasConcept C90924648 @default.
• W3020130780 hasConceptScore W3020130780C126322002 @default.
• W3020130780 hasConceptScore W3020130780C134018914 @default.
• W3020130780 hasConceptScore W3020130780C168563851 @default.
• W3020130780 hasConceptScore W3020130780C203092338 @default.
• W3020130780 hasConceptScore W3020130780C2777180221 @default.
• W3020130780 hasConceptScore W3020130780C2778163477 @default.
• W3020130780 hasConceptScore W3020130780C2778270857 @default.
• W3020130780 hasConceptScore W3020130780C2779306644 @default.
• W3020130780 hasConceptScore W3020130780C2779339615 @default.
• W3020130780 hasConceptScore W3020130780C2780221984 @default.
• W3020130780 hasConceptScore W3020130780C2780533449 @default.
• W3020130780 hasConceptScore W3020130780C2910068830 @default.
• W3020130780 hasConceptScore W3020130780C2987047532 @default.
• W3020130780 hasConceptScore W3020130780C555293320 @default.
• W3020130780 hasConceptScore W3020130780C71924100 @default.
• W3020130780 hasConceptScore W3020130780C84393581 @default.
• W3020130780 hasConceptScore W3020130780C90924648 @default.
• W3020130780 hasIssue "1" @default.
• W3020130780 hasLocation W30201307801 @default.

• next